Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Support Care Cancer ; 24(5): 2067-2074, 2016 May.
Article in English | MEDLINE | ID: mdl-26542274

ABSTRACT

PURPOSE: This study aims to determine the numbers of patients with advanced cancer receiving polypharmacy at the end of their lives and analyze differences in drug prescription at a general oncology ward and a dedicated palliative care ward. METHODS: A retrospective single-center cohort study at a university hospital with a large cancer center was conducted. The charts of 100 patients who had died because of advanced cancer were reviewed; data concerning sociodemographic variables and medications were collected at four predefined time points (9, 6, 3, 0 days before death). RESULTS: Nine days before death, polypharmacy was registered in 95 % of patients; they had prescriptions for 11 (9-13) different medications per day (median, IQR). Although this number dropped significantly, on the last day as many as 61 % of the patients were still taking more than 4 drugs (median 6.5, IQR 4-9). No significant difference was noted between the oncology ward and the palliative care ward. Polypharmacy was largely dependent on the patients' ECOG performance status as well as the type of ward, the number of days before death, and age. It was not influenced by gender, the duration of hospital stays, and the devices facilitating drug administration. The medications fulfilled the requirements of palliative care in the majority of patients; 90 % received treatment for pain and anxiety. Patients treated at the palliative ward received more opioids and psychoactive drugs while those at the oncology ward received more anti-cancer drugs and fluids. CONCLUSIONS: Polypharmacy still is a problem in the large majority of patients with terminal cancer. Further studies should be focused on the patients' quality of life, drug interactions, and adverse events.


Subject(s)
Analgesics, Opioid/therapeutic use , Antineoplastic Agents/therapeutic use , Neoplasms/drug therapy , Pain/drug therapy , Palliative Care , Polypharmacy , Adult , Aged , Aged, 80 and over , Drug Interactions , Female , Humans , Longitudinal Studies , Male , Middle Aged , Neoplasms/mortality , Neoplasms/psychology , Pain/prevention & control , Pain/psychology , Practice Guidelines as Topic , Quality of Life , Retrospective Studies , United States/epidemiology
2.
Support Care Cancer ; 23(8): 2335-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25577505

ABSTRACT

PURPOSE: Discharging a patient admitted to an inpatient palliative care unit (PCU) is a major challenge. A predictor of the feasibility of home discharge at the time of admission would be very useful. We tried to identify such predictors in a prospective observational study. METHODS: Sixty patients with advanced cancer admitted to a PCU were enrolled. Sociodemographic data were recorded and a panel of laboratory tests performed. The Karnofsky performance status scale (KPS) and the palliative performance scale (PPS) were determined. A palliative care physician and nurse independently predicted whether the patient would die at the ward. The association of these variables with home discharge or death at the PCU was determined. RESULTS: Sixty patients (26 men and 34 women) with advanced cancer were included in the study. Discharge was achieved in 45 % of patients, while 55 % of patients died at the PCU. The median stay of discharged patients was 15.2 days, and the median stay of deceased patients 13.6 days. Median KPS and PPS on admission was 56.2 % for the entire group and significantly higher for discharged patients (60.7 %) compared to deceased patients (52.4 %). Median BMI on admission was 22.8 in the entire group and was similar in discharged and deceased patients. No correlation was found between a panel of sociodemographic variables and laboratory tests with regard to discharge or death. In a binary logistic regression model, the probability of discharge as estimated by the nurse/physician and the KPS and PPS were highly significant (p = 0.008). CONCLUSION: Estimation by a nurse and a physician were highly significant predictors of the likelihood of discharge and remained significant in a multivariate logistic regression model including KPS and PPS. Other variables, such as a panel of laboratory tests or sociodemographic variables, were not associated with discharge or death.


Subject(s)
Neoplasms/mortality , Neoplasms/therapy , Palliative Care/methods , Adult , Aged , Aged, 80 and over , Female , Hospitalization , Humans , Karnofsky Performance Status , Logistic Models , Male , Middle Aged , Neoplasms/diagnosis , Patient Discharge , Prospective Studies
3.
Ann Palliat Med ; 3(4): 244-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25841904

ABSTRACT

OBJECTIVES: Home discharge after hospital admission to an inpatient palliative care unit (PCU) is a major challenge. Dysfunction of the autonomic nervous system is commonly observed in patients with advanced cancer in this setting. The aim of this prospective observational study was to determine whether the measurement of heart rate variability (HRV) by assessing parameters of the autonomic nervous system on a 24-h-ECG at the time of admission to the PCU was correlated with the likelihood of discharge. METHODS: Sixty hospitalized patients with advanced cancer of distinct origin, admitted to a PCU, were enrolled consecutively. The Karnofsky performance status scale (KPS) and the palliative performance scale (PPS) were obtained. HRV was measured over one day (20-24 hours) using a portable five-point ECG. The aim of the study was to compare HRV measurements in patients who could be discharged and those who died. The association of these variables with home discharge or death at the PCU was calculated. RESULTS: Discharge was achieved in 45% of patients while 55% of patients died. Median KPS and median PPS on admission were significantly higher in discharged patients than in those who died (P=0.001). Patients who were discharged tended to have a higher HRV, although the difference was not significant. CONCLUSIONS: KPS and PPS were significant predictors of the likelihood of discharge while HRV did not predict discharge.

4.
Eur J Oncol Nurs ; 17(1): 70-4, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22369950

ABSTRACT

BACKGROUND: Discrepancies exist in estimation of quality of life (QL) by patients and caregivers but underlying factors are incompletely characterised. METHODS: QL of 153 patients was estimated by themselves, by 70 nurses and by 53 physicians in a cross-sectional study. Variables which could influence inter-rater agreement were evaluated. RESULTS: Inter-rater agreement of QL was fair (r = .292) between patients and nurses and between patients and physicians (r = .154). Inter-rater agreement with nurses was significantly lower concerning fatigue and pain for patients with a Karnofsky Index <50 when compared to patients with a KI > 50. Their inter-rater agreement with physicians was significantly lower for fatigue, pain and physical functioning. Agreement on the degree of anxiety was significantly (p = .009) better for female patients. Agreement on the need for social assistance (p = .01) and physical functioning (p = .03) was significantly better for male patients. Agreement with patients on their physical functioning was significantly (p = .03) better for male nurses and male physicians (r = .944) than for female nurses and female physicians (r = .674). CONCLUSIONS: Our study showed that estimation of overall QL of patients by professional caregivers is inaccurate. Inter-rater agreement was influenced by KI of patients, by gender of patients and caregivers and by professional experience of nurses.


Subject(s)
Attitude of Health Personnel , Neoplasms/nursing , Neoplasms/psychology , Nurses/psychology , Palliative Care/psychology , Physicians/psychology , Quality of Life , Adult , Aged , Aged, 80 and over , Austria , Cross-Sectional Studies , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged , Prospective Studies , Self Report , Sex Factors , Surveys and Questionnaires
5.
Wien Med Wochenschr ; 162(1-2): 8-10, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22328048

ABSTRACT

Delirium is still one of the most common and distressing symptoms in palliative care patients. Causes and pathophysiology of this neuropsychiatric dysfunction are multifactorial. Recent studies indicate that the interaction of special triggers facilitates development of delirium. Some of them are reversible. This case report presents a reversible delirium in an advanced cancer patient and offers a list of possible delirogen medications. This list might be useful to prevent delirium, particularly in older people.


Subject(s)
Bone Neoplasms/psychology , Bone Neoplasms/secondary , Breast Neoplasms/psychology , Carcinoma, Intraductal, Noninfiltrating/psychology , Carcinoma, Intraductal, Noninfiltrating/secondary , Carcinoma, Lobular/psychology , Carcinoma, Lobular/secondary , Delirium/psychology , Neoplasms, Multiple Primary/psychology , Palliative Care/methods , Palliative Care/psychology , Amines/administration & dosage , Amines/adverse effects , Analgesics/administration & dosage , Analgesics/adverse effects , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Bone Neoplasms/pathology , Bone Neoplasms/therapy , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Intraductal, Noninfiltrating/therapy , Carcinoma, Lobular/pathology , Cyclohexanecarboxylic Acids/administration & dosage , Cyclohexanecarboxylic Acids/adverse effects , Delirium/chemically induced , Delirium/drug therapy , Disease Progression , Dose-Response Relationship, Drug , Drug Therapy, Combination , Female , Gabapentin , Humans , Lorazepam/administration & dosage , Midazolam/administration & dosage , Middle Aged , Neoplasm Staging , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/therapy , Spinal Neoplasms/pathology , Spinal Neoplasms/psychology , Spinal Neoplasms/secondary , Spinal Neoplasms/therapy , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/adverse effects
6.
Support Care Cancer ; 20(9): 2183-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22119936

ABSTRACT

BACKGROUND: There is limited data on the use of thromboprophylaxis in patients with advanced cancer. We therefore aimed to study the practice of thromboprophylaxis in palliative care units in Austria. METHODS: We monitored use, indication, and contraindications to thromboprophylaxis in 134 patients hospitalized in 21 palliative care units in a prospective, cross-sectional study. RESULTS: Forty-seven percent of patients were on low molecular weight heparin on the day of the study for primary or secondary thromboembolism. Thromboprophylaxis had been withdrawn in 18% of the patients upon admission to the palliative care unit. Contraindications for thromboprophylaxis were present in 27% of all patients. Cancer was present in 86% of the patients. The use of thromboprophylaxis was similar in cancer patients and in non-cancer patients (49% vs. 42%). Contraindications for thromboprophylaxis were present in 24% of all cancer patients. Significantly more bedridden cancer patients had contraindications for prophylaxis when compared with mobile cancer patients (35% vs. 16%; p = 0.03). Low performance status was by far the most frequent contraindication among these patients (89%). Seventy-one percent of all bedridden cancer patients were treated in accordance with common guidelines for thromboprophylaxis when contraindications were taken into account. Eighty-seven percent of patients who had been involved in decision making opted for getting prophylaxis. CONCLUSIONS: Our data reveal that about half of all cancer patients in palliative care units are treated with thromboprophylaxis. Low performance status was the most frequent contraindication for thromboprophylaxis.


Subject(s)
Palliative Care , Thrombosis/prevention & control , Aged , Aged, 80 and over , Austria , Female , Hospitalization , Humans , Male , Practice Guidelines as Topic , Prospective Studies , Surveys and Questionnaires
7.
Wien Klin Wochenschr ; 122(1-2): 45-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20177859

ABSTRACT

Oncologists differ widely in their attitudes towards palliative care and services. These attitudes depend on a number of individual and society-based variables. It is recommended that palliative care be started early in the disease trajectory of patients with a life-threatening disease but in Austria we lack data on oncologists' adherence to this recommendation. We surveyed 785 oncologists in Austria by presenting the clinical course of a hypothetical patient with primary metastatic breast cancer from diagnosis until death. The majority of oncologists would involve palliative care services when the patient's Karnofsky index (KI) was < 50, and hospice services when the KI was < 40. Special training in palliative care was significantly associated with early use of hospice services. Reasons for not involving palliative care and hospice services earlier than indicated were systematically evaluated and included, among others, "fear of destroying the patient's hopes" (36% of respondents with regard to palliative services, 57% with regard to hospices). Overall, 67% of the oncologists would inform the patient about the malignant nature of her disease and the anticipated limitation of her life expectancy at the time of diagnosis. Issuing an advance directive would be discussed by only 25% at that time. Our data show that oncologists involve palliative care services at an advanced stage of disease in patients with primary metastatic cancer and that information about malignancy and the incurable nature of the disease is not uniformly provided at the time of diagnosis.


Subject(s)
Advance Directives/statistics & numerical data , Attitude of Health Personnel , Breast Neoplasms/nursing , Breast Neoplasms/secondary , Hospices/statistics & numerical data , Palliative Care/statistics & numerical data , Physicians/statistics & numerical data , Adult , Austria/epidemiology , Breast Neoplasms/epidemiology , Data Collection , Female , Humans , Male , Middle Aged , Terminal Care/statistics & numerical data
8.
Support Care Cancer ; 18(3): 367-72, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19484481

ABSTRACT

AIM: The purpose of advance directives (AD) is to preserve the patient's autonomy at the end of his/her life. In a cohort study, we investigated attitudes towards AD in hospitalized patients with malignant disease. MATERIALS AND METHODS: All patients were informed about the basic features of AD in a standardized manner by a single independent physician. One hundred and eight (39 women, 69 men; mean age 56.6 +/- 14.9 years) of 140 invited patients completed the study. MAIN RESULTS: Five percent of patients (5/108) already had an AD; 85% (92/108) did not wish to issue an AD. "Full confidence in physicians" (22%) and "not important for me at the moment" (15%) were the most frequently stated reasons for not issuing an AD. Only 10% (11/108) of patients decided to complete an AD. Their decision was not related to a specific diagnosis or a number of socio-demographic variables that were studied. Patients who decided in favor of an AD had significantly higher Hospital Anxiety and Depression Scale (HADS-D) score than those who decided against it (HADS-D, 8.3 +/- 5.0 vs.5.8 +/- 4.1, p = 0.035). The patients' HADS depression score was negatively associated with their Karnofsky index (r = -0.232, p = 0.017). CONCLUSIONS: Our data reveal a scarce demand for AD in our population of hospitalized cancer patients. Patients who wanted to issue an AD had a high HADS-D, which is associated with a low performance status.


Subject(s)
Advance Directive Adherence/statistics & numerical data , Advance Directives/psychology , Advance Directives/statistics & numerical data , Health Knowledge, Attitudes, Practice , Neoplasms/epidemiology , Neoplasms/psychology , Adult , Aged , Aged, 80 and over , Austria , Cohort Studies , Female , Humans , Male , Middle Aged , Population Surveillance , Young Adult
9.
Am J Hosp Palliat Care ; 25(2): 127-31, 2008.
Article in English | MEDLINE | ID: mdl-18198364

ABSTRACT

Study-based guidelines on thromboprophylaxis are not available for palliative care patients. The authors asked a panel of academic medical experts in palliative care, oncology, blood coagulation, and intensive care to select a prophylactic regimen out of 5 predefined options for a virtual patient with advanced bronchial cancer in different clinical settings. Primary prophylaxis for venous thromboembolism was withdrawn by all physicians when the patient had a Karnovsky's index of 10 and was described as dying. It was given by 25% of physicians when the patient had a Karnovsky's index of 20 and by 85% when Karnovsky's index 40 was still 40. Similar results were obtained in the situation of secondary prophylaxis of venous thromboembolism and when the patient was described as having a history of chronic atrial fibrillation. This data clearly show that thromboprophylaxis is delivered according to a compound estimate of risks and benefits of such prophylaxis in a specific palliative care situation.


Subject(s)
Attitude of Health Personnel , Critical Care/methods , Fibrinolytic Agents/therapeutic use , Medical Oncology/methods , Palliative Care/methods , Patient Selection , Adult , Aged , Anticoagulants/adverse effects , Anticoagulants/therapeutic use , Atrial Fibrillation/etiology , Atrial Fibrillation/prevention & control , Austria , Bronchial Neoplasms/complications , Female , Fibrinolytic Agents/adverse effects , Guideline Adherence , Humans , Karnofsky Performance Status , Male , Middle Aged , Practice Guidelines as Topic , Practice Patterns, Physicians' , Prognosis , Quality of Life , Surveys and Questionnaires , Venous Thromboembolism/etiology , Venous Thromboembolism/prevention & control , Withholding Treatment
SELECTION OF CITATIONS
SEARCH DETAIL
...